CODEX: A Prognostic Index for chronic obstructive pulmonary disease in Internal Medicine.

Rev Clin Esp (Barc)

Servicio de Medicina Interna, Hospital Vall d'Hebron, Barcelona, España. Electronic address:

Published: November 2015

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rce.2015.09.006DOI Listing

Publication Analysis

Top Keywords

codex prognostic
4
prognostic chronic
4
chronic obstructive
4
obstructive pulmonary
4
pulmonary disease
4
disease internal
4
internal medicine
4
codex
1
chronic
1
obstructive
1

Similar Publications

Biliary tract cancers (BTC) are rare lethal malignancies arising along the biliary tree. Unfortunately, effective therapeutics are lacking and the prognosis remains dismal even for patients eligible for surgical resection. Therefore, novel therapeutic approaches along with early detection strategies and prognostic markers are urgently needed.

View Article and Find Full Text PDF

Background: Multiplexed immunofluorescence (mIF) staining, such as CODEX and MIBI, holds significant clinical value for various fields, such as disease diagnosis, biological research, and drug development. However, these techniques are often hindered by high time and cost requirements.

Methods: Here we present a Multimodal-Attention-based virtual mIF Staining (MAS) system that utilises a deep learning model to extract potential antibody-related features from dual-modal non-antibody-stained fluorescence imaging, specifically autofluorescence (AF) and DAPI imaging.

View Article and Find Full Text PDF

Pancreatic ductal adenocarcinoma (PDAC) represents one of the only cancers with an increasing incidence rate and is often associated with intra- and peri-tumoral scarring, referred to as desmoplasia. This scarring is highly heterogeneous in extracellular matrix (ECM) architecture and plays complex roles in both tumor biology and clinical outcomes that are not yet fully understood. Using hematoxylin and eosin (H&E), a routine histological stain utilized in existing clinical workflows, we quantified ECM architecture in 85 patient samples to assess relationships between desmoplastic architecture and clinical outcomes such as survival time and disease recurrence.

View Article and Find Full Text PDF
Article Synopsis
  • Circulating tumor RNA (ctRNA) is a promising new liquid biomarker that can provide valuable noninvasive insights into gene expression related to cancer, eliminating the need for traditional tissue biopsies.
  • The research highlights how higher levels of cancer-specific ctRNA can enhance detection and analyze conditions where circulating tumor DNA (ctDNA) is insufficient.
  • The review also covers the current understanding of ctRNAs in colorectal cancer diagnosis and treatment, along with practical considerations for analyzing plasma ctRNA, including storage, isolation, and detection methods.
View Article and Find Full Text PDF

Background: Cell free RNA (cfRNA) contains transcript fragments from multiple cell types, making it useful for cancer detection in clinical settings. However, the pathophysiological origins of cfRNAs in plasma from colorectal cancer (CRC) patients remain unclear.

Methods: To identify the tissue-specific contributions of cfRNAs transcriptomic profile, we used a published single-cell transcriptomics profile to deconvolute cell type abundance among paired plasma samples from CRC patients who underwent tumor-ablative surgery.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!